FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 271

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
LQDA Nasdaq Liquidia Corporation 2830
LSTA Nasdaq Lisata Therapeutics, Inc. 2830
LXEO Nasdaq Lexeo Therapeutics, Inc. 2830
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2830
LZAGY Over the counter Lonza Group AG 2830
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MBIO Nasdaq Mustang Bio, Inc. 2830
MBX Nasdaq MBX Biosciences, Inc. 2830
MENS Nasdaq Jyong Biotech Ltd. 2830
MESO Nasdaq Mesoblast Limited 2830
MGNX Nasdaq MacroGenics, Inc. 2830
MGRX Nasdaq Mangoceuticals, Inc. 2830
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2830
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MLTX Nasdaq MoonLake Immunotherapeutics 2830
MLYS Nasdaq Mineralys Therapeutics, Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MRK New York Merck & Co., Inc. 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MSLE Nasdaq Satellos Bioscience Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
MTVA Nasdaq MetaVia Inc. 2830
NATR Nasdaq Natures Sunshine Products, Inc. 2830
NCEL Nasdaq NewcelX Ltd. 2830
NEUP Nasdaq Neuphoria Therapeutics Inc. 2830
NNVC NYSE American NanoViricides, Inc. 2830
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
NVS New York Novartis AG 2830
NXTS Nasdaq Nexentis Technologies Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
OGEN NYSE American Oragenics, Inc. 2830
OGN New York Organon & Co. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2830
ONCO Nasdaq Onconetix, Inc. 2830
OPK Nasdaq OPKO Health, Inc. 2830
OPTH Nasdaq Optimi Health Corp. 2830
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2830
PALI Nasdaq Palisade Bio, Inc. 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBLS Nasdaq Parabilis Medicines, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PEPG Nasdaq PepGen Inc. 2830
PFE New York Pfizer Inc. 2830
PG New York The Procter & Gamble Company 2830
PHAR Nasdaq Pharming Group N.V. 2830
PHIO Nasdaq Phio Pharmaceuticals Corp. 2830
Results 150 through 200 of 271